|
|
|
2004 Archives
|
|
Bayer AG today announced that an agreement has been signed to contribute the assets of its worldwide plasma products business to NPS BioTherapeutics, Inc., a newly formed corporation controlled by affiliates of Cerberus Capital Management, L.P., New York, and Ampersand Ventures, Wellesley, Massachusetts. |
|
|
|
ProGene Biomedical, Inc. (d/b/a IBT Reference Laboratory), a national clinical reference laboratory specializing in clinical immunology and allergy testing, today announced that it has received $5 million in equity financing from Ampersand Ventures. |
|
|
|
Magellan Biosciences, Inc. announced today that it has acquired Dynex Technologies, a global supplier of microplate instrumentation and automation products for the biomedical research, drug discovery and clinical diagnostic markets headquartered in Chantilly, VA. Magellan acquired the Dynex business from Capital Genomix, Inc., a biotechnology company in Gaithersburg, MD. Financial terms were not disclosed. |
|
|
|
Proficiency, the acclaimed leader in engineering collaboration and design data interoperability, today announced it has received an additional $12 million in its third major round of financing. |
|
|
|
Ampersand Ventures announced today that it has acquired privately owned ESA, Inc., a global supplier of analytical instruments and kits for the biomedical research, drug discovery and clinical diagnostic markets. |
|
|
